ResearcherWest China Hospital of Sichuan UniversityActive in the last 2 years
Xin Wang
Matched on ORCID iD 0000-0003-1059-9953; OpenAlex author ID A5102563288. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 4
- Postoperative survival prediction in pancreatic ductal adenocarcinoma and adenosquamous carcinoma: development of the machine learning-based model. Co-author DOI 10.1097/js9.0000000000004008↗
- PLEK2 promotes migration and invasion in pancreatic ductal adenocarcinoma by MMP1 through IL-17 pathway. Last author DOI 10.1007/s11010-024-05078-x↗
- CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-024-57417-z↗
- Dual and triple gene combinations of KRT5, KRT17, and S100A2 identify basal-like subtype of pancreatic ductal adenocarcinoma and correlate with survival outcom… Co-author DOI 10.1096/fj.202302484rr↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bing Peng · 3 shared papers, 2024–2026 · strength 0.70
- Paper Postoperative survival prediction in pancreatic ductal adenocarcinoma and adenosquamous carcinoma: development of the m… DOI 10.1097/js9.0000000000004008↗
- Paper PLEK2 promotes migration and invasion in pancreatic ductal adenocarcinoma by MMP1 through IL-17 pathway. DOI 10.1007/s11010-024-05078-x↗
- Paper CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcin… DOI 10.1038/s41598-024-57417-z↗
- He Cai · 3 shared papers, 2024–2026 · strength 0.70
- Paper Postoperative survival prediction in pancreatic ductal adenocarcinoma and adenosquamous carcinoma: development of the m… DOI 10.1097/js9.0000000000004008↗
- Paper PLEK2 promotes migration and invasion in pancreatic ductal adenocarcinoma by MMP1 through IL-17 pathway. DOI 10.1007/s11010-024-05078-x↗
- Paper CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcin… DOI 10.1038/s41598-024-57417-z↗
- Qiangxing Chen · 3 shared papers, 2024–2025 · strength 0.60
- Paper PLEK2 promotes migration and invasion in pancreatic ductal adenocarcinoma by MMP1 through IL-17 pathway. DOI 10.1007/s11010-024-05078-x↗
- Paper CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcin… DOI 10.1038/s41598-024-57417-z↗
- Paper Dual and triple gene combinations of KRT5, KRT17, and S100A2 identify basal-like subtype of pancreatic ductal adenocarc… DOI 10.1096/fj.202302484rr↗
- Zhong Wu · 2 shared papers, 2024–2026 · strength 0.46
- Paper Postoperative survival prediction in pancreatic ductal adenocarcinoma and adenosquamous carcinoma: development of the m… DOI 10.1097/js9.0000000000004008↗
- Paper Dual and triple gene combinations of KRT5, KRT17, and S100A2 identify basal-like subtype of pancreatic ductal adenocarc… DOI 10.1096/fj.202302484rr↗
- Ke Cheng · 2 shared papers, 2024–2025 · strength 0.42
- Paper PLEK2 promotes migration and invasion in pancreatic ductal adenocarcinoma by MMP1 through IL-17 pathway. DOI 10.1007/s11010-024-05078-x↗
- Paper CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcin… DOI 10.1038/s41598-024-57417-z↗
- Tianrui Kuang · 1 shared paper, 2026 · strength 0.28
- Ke Cheng · 1 shared paper, 2024 · strength 0.18
- Bing Peng · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.